Cell-free DNA in Kidney Transplantation – What Nurses Need to Know
Wed, Dec 2, 2020 11:00 AM - 12:00 PM CST
Join ITNS Industry Relations Council Member, Natera, to hear from Mayon Ashton, MSN, RMN, RN-BC on what nurses need to know about cell-free DNA in kidney transplantation.
This presentation will review the basics of genetics leading into the use of Cell-free DNA (cfDNA). cfDNA is the term used to describe the small fragments of DNA that occur naturally and circulate in the bloodstream.
Advanced technology of using cfDNA has improved testing and screening options for transplant recipients. Donor-derived cell-free DNA (dd-cfDNA) can assess the amount of cell-free DNA in an organ recipient's blood that originates from the donor. Elevated levels of cfDNA in the recipients blood may signify an increase in cell death from kidney injury and/or rejection.
Because patients are curious about this test, this presentation will cover patient education points for transplant coordinators.
• Understand the basics of cell-free DNA testing,
• Appreciate the benefits to kidney patients, and
• Become familiar with how to provide patient education on cell-free DNA testing.
Speaker: Mayon Ashton, MSN, RMN, RN-BC
Ms. Ashton is an Advanced Practice Nurse at Largo Medical Center in Largo, FL. She has 19 years of nursing experience and many of those in kidney transplant, including pre and post transplant coordinator experience with the last six years exclusively in post-transplant.